SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-044727
Filing Date
2018-08-14
Accepted
2018-08-14 16:48:03
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv500777_10q.htm 10-Q 613038
2 EXHIBIT 31.1 tv500777_ex31-1.htm EX-31.1 8957
3 EXHIBIT 32.1 tv500777_ex32-1.htm EX-32.1 4111
  Complete submission text file 0001144204-18-044727.txt   13282046

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20180630.xml EX-101.INS 5036411
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20180630.xsd EX-101.SCH 68331
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20180630_cal.xml EX-101.CAL 37202
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20180630_def.xml EX-101.DEF 495987
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20180630_lab.xml EX-101.LAB 442493
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20180630_pre.xml EX-101.PRE 516762
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 181018440
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1